Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

13 treatments under study, led by Comparison Of Atropine And Isoprenaline

Research Leaders

10 sponsors active, led by Charles University, Czech Republic

Related Conditions

Often studied with 16 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 8 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (3)
Phase 4 (3)

Trial Status

Unknown4
Completed2
Recruiting2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (8)

Research Network

Common Treatments

  • Comparison Of Atropine And Isoprenaline1
  • Risk Control Strategy1
  • Singlesyringe Adenosine1
  • Electrocardiography1
  • Sotalol1

Active Sponsors

  • Charles University, Czech Republic1
  • Assistance Publique - Hôpitaux de Paris1
  • Medical University of Lodz1
  • University of Sao Paulo General Hospital1
  • Department of Internal Medicine I - Cardiology1

Top Investigators

Related Conditions

  • Septic Shock2
  • Atrial Fibrillation2
  • Ventricular Arrhythmias And Cardiac Arrest1
  • Chronic Lymphocytic Leukemiasmall Lymphocytic Lymphoma1
  • Proarrhythmia1

Activity Timeline